United states

Replimune Gets Third Try at FDA Approval After Makary Departure – WSJ

3 days ago
2 Views
1 Min Read
  1. Replimune Gets Third Try at FDA Approval After Makary Departure  WSJ
  2. Replimune to resubmit twice-rejected drug for approval after FDA shakeup  CNBC
  3. Replimune Soars After FDA Reconsiders Denial of Skin Cancer Drug  Bloomberg.com
  4. FDA to prioritize RP1 melanoma review in cancer killing 8,500 a year  Stock Titan
  5. Replimune expected to announce agreement with FDA to resubmit its advanced melanoma treatment for approval – WSJ  marketscreener.com

Add Comment

Click here to post a comment